Coldstream Capital Management Inc Monte Rosa Therapeutics, Inc. Call Options Transaction History
Coldstream Capital Management Inc
- $4.64 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding GLUE
# of Institutions
109Shares Held
53.1MCall Options Held
117KPut Options Held
15.9K-
Nea Management Company, LLC Timonium, MD7.69MShares$35.6 Million3.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.64MShares$30.8 Million0.0% of portfolio
-
Versant Venture Management, LLC San Francisco, CA5.65MShares$26.2 Million54.61% of portfolio
-
Baker Bros. Advisors LP New York, NY4.92MShares$22.8 Million0.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.65MShares$21.5 Million0.35% of portfolio
About Monte Rosa Therapeutics, Inc.
- Ticker GLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,713,900
- Market Cap $216M
- Description
- Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...